Vimarsana
Biggest News Aggregation in the World

Page 8 - Genmark Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genmark Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genmark Diagnostics Today - Breaking & Trending Today

Influenza Diagnostics Market Demand Is Better Met With Government Policies and Collaborations - Vimarsana News

Influenza Diagnostics Market Demand Is Better Met With Government Policies and Collaborations

/PRNewswire/ -- Government policies provide a much-required impetus for the influenza diagnostics market to grow exponentially. The initiatives to counter...

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Hepatitis Testing Market worth $3.6 billion by 2026 - Exclusive Report by MarketsandMarkets™

Hepatitis Testing Market worth $3.6 billion by 2026 – Exclusive Report by MarketsandMarkets™

Pathogenomix Developing Infectious Disease Testing Platform Enabled by Cloud-Based Analytics, NGS - Vimarsana News

Pathogenomix Developing Infectious Disease Testing Platform Enabled by Cloud-Based Analytics, NGS

The firm obtained FDA breakthrough device designation for an NGS approach to identify up to 400 bacterial pathogens used to diagnose sepsis and other bacterial infections.

Roche Diagnostics Revenues Grow 29 Percent in 2021 - Vimarsana News

Roche Diagnostics Revenues Grow 29 Percent in 2021

The firm saw growth in all of its diagnostics segments, including point-of-care testing and molecular laboratory testing.